MedPath

AURO-BUSPIRONE

AURO-BUSPIRONE

Approved
DIN Number

02500213

Drug Class

Human

Market Date

Oct 30, 2020

Company
HC

auro pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02500213
AIG Number0116263001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05BE01 BUSPIRONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:24.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

BUSPIRONE HYDROCHLORIDEActive
Strength: 10 MG
Monograph: BUSPIRONE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.